Αποτελέσματα Αναζήτησης
24 Φεβ 2017 · Potential predictors of occurrence of an adverse event include sex (relative risk [RR] = 1.5), treatment with insulin (RR = 2.17), years with diabetes (RR = 3.85), and baseline glycated hemoglobin (HbA1c) (odds ratio [OR] = 1.67).
People with both cancer and diabetes may have an increased risk of toxicities, hospital admissions and morbidity, with hyperglycaemia potentially attenuating the efficacy of chemotherapy often secondary to dose reductions and early cessation. Numerous
23 Δεκ 2020 · Patients treated with chemotherapy within 1–5 years of initial diagnosis of colorectal cancer were at approximately 30% higher risk of T2D. One study found that 48% of T2D was preventable with optimal management during the process of patient care.
13 Δεκ 2021 · Multiple cancer therapies cause diabetes including well-established medications such as glucocorticoids and novel cancer therapies such as immune checkpoint inhibitors (CPIs) and phosphoinositide 3-kinase (PI3K) inhibitors. Recent Findings.
People with both cancer and diabetes may have an increased risk of toxicities, hospital admissions and morbidity, with hy-perglycaemia potentially attenuating the efficacy of chemotherapy often secondary to dose reductions and early cessation.
2 Φεβ 2023 · The risk of severe adverse events after chemotherapy—including infection, hematological disorders, endocrine disorders and deterioration of the general condition—was significantly high in patients with diabetes.
19 Δεκ 2023 · You and your doctor might need to plan chemotherapy a bit more carefully if you are diabetic. Some chemotherapy combinations include steroids and these might upset your blood sugar. Your doctor might ask you to have a blood test to check your sugar levels before you start treatment.
